Delving into the Latest Updates on Apath LLC with Synapse

Overview

Tags

Digestive System Disorders

Infectious Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Infectious Diseases	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

HCV NS4B	1

Author: Moser, Michael J. ; Germer, J. J. ; Podzorski, Diane S. ; Yao, Joseph D. ; Olivo, Paul D. ; Ledeboer, Nathan A. ; D'Amore, Krista L. ; Johnson, Scott C. ; O'Guin, Andy K. ; Mulligan, Elizabeth K. ; Newman, Andrew C. ; Vaughan, Kimberly A. ; Di Bisceglie, Adrian ; Arens, Max Q. ; Elagin, Slava A.

ABSTRACTA prototype, real-time reverse-transcription PCR assay, based on MultiCode-RTx technology, quantifying hepatitis C virus (HCV) RNA by targeting the HCV 3′ untranslated region demonstrated linearity over 7 logs, with a good correlation between the quantitative results of this assay and the results of two commercially available comparator assays for 466 clinical specimens comprising all six HCV genotypes.

100 Deals associated with Apath LLC

Login to view more data

100 Translational Medicine associated with Apath LLC

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 24 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Preclinical

1

Login to view more data